|
|
|
|
| LEADER |
01468nam a2200445Ia 4500 |
| 001 |
10.18176-jiaci.0729 |
| 008 |
220510s2022 CNT 000 0 und d |
| 020 |
|
|
|a 10189068 (ISSN)
|
| 245 |
1 |
0 |
|a Anaphylactic Reactions With 3 Nonrelated Drugs (Gadoteridol, Paclitaxel, Bevacizumab) in a Patient With Severe Comorbidities
|
| 260 |
|
0 |
|b NLM (Medline)
|c 2022
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.18176/jiaci.0729
|
| 650 |
0 |
4 |
|a anaphylaxis
|
| 650 |
0 |
4 |
|a Anaphylaxis
|
| 650 |
0 |
4 |
|a bevacizumab
|
| 650 |
0 |
4 |
|a Bevacizumab
|
| 650 |
0 |
4 |
|a Chemotherapy
|
| 650 |
0 |
4 |
|a drug hypersensitivity
|
| 650 |
0 |
4 |
|a Drug Hypersensitivity
|
| 650 |
0 |
4 |
|a Excipients
|
| 650 |
0 |
4 |
|a gadolinium
|
| 650 |
0 |
4 |
|a Gadolinium
|
| 650 |
0 |
4 |
|a gadoteridol
|
| 650 |
0 |
4 |
|a heterocyclic compound
|
| 650 |
0 |
4 |
|a Heterocyclic Compounds
|
| 650 |
0 |
4 |
|a human
|
| 650 |
0 |
4 |
|a Humans
|
| 650 |
0 |
4 |
|a Monoclonal antibodies
|
| 650 |
0 |
4 |
|a Multiple drug hypersensitivity syndrome
|
| 650 |
0 |
4 |
|a organometallic compound
|
| 650 |
0 |
4 |
|a Organometallic Compounds
|
| 650 |
0 |
4 |
|a paclitaxel
|
| 650 |
0 |
4 |
|a Paclitaxel
|
| 700 |
1 |
|
|a Alfaya Arias, T.
|e author
|
| 700 |
1 |
|
|a Alonso-Díaz-de-Durana, M.D.
|e author
|
| 700 |
1 |
|
|a Álvarez-Twose, I.
|e author
|
| 700 |
1 |
|
|a González-Bravo, L.
|e author
|
| 700 |
1 |
|
|a Laiseca García, J.
|e author
|
| 700 |
1 |
|
|a Nieto Nieto, A.
|e author
|
| 700 |
1 |
|
|a Tejedor Alonso, M.A.
|e author
|
| 773 |
|
|
|t Journal of investigational allergology & clinical immunology
|
